Loading....
The activities of the Let’s Talk Prostate Cancer (LTPC) Expert Group are funded by Astellas Pharma Inc., Amgen Inc and Pfizer Inc, which collectively contribute to and support the objectives of the Expert group.
Astellas Pharma Inc. have full and exclusive editorial control over the LTPC Website
By admin

On 5 December, Let’s Talk Prostate Cancer organised the event “Uniting for Prostate Cancer: Advancing Screening and Care in the EU,” at the European Parliament, hosted by MEP Romana Jerkovic. The event brought together European Union (EU) policymakers, patient advocates, healthcare authorities, and key stakeholders to discuss the importance of early screening and detection of prostate cancer in the EU.

Speakers shared insights on the EU’s progress and ongoing challenges, while patients and advocates highlighted the psychological side of prostate cancer treatment. Representatives from the European Commission, cancer organisations, and regional authorities from Italy, Spain, and the Czech Republic discussed policy cooperation and best practices for screening programs.

Key opinion leaders from the European Association of Urology (EAU), the European Cancer Organisation (ECO), and All.Can International shared their hopes for the future mandate.

As mentioned by our host MEP Romana Jerkovic, LTPC is committed to improving early screening and high-quality detection practices, enhancing patient outcomes across the EU. Let’s unite and drive progress in the fight against prostate cancer!

Read the full report in the attachment.

LTPC Post Event Report 2024

Leave a Reply

Your email address will not be published. Required fields are marked *